[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Cancer Biomarkers Market  

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Type Overview

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Protein Biomarker

4.3       Genetic Biomarker

4.4       Others

5          By Cancer Type Overview

5.1       Introduction

5.1.1    Market Size & Forecast (Value)

5.2       Breast Cancer

5.3       Lung Cancer

5.4       Colorectal Cancer

5.5       Prostate Cancer

5.6       Non-Hodgkin's lymphoma

5.7       Melanoma

5.8       Leukemia

5.9       Thyroid Cancer

5.10     Bladder Cancer

5.11     Kidney Cancer

5.12     Other Cancers Blood Test

6          By Type Overview

6.1       Introduction

6.1.1    Market Size & Forecast (Value)

6.2       Medical Therapies

6.3       Omics Technologies

6.4       Genomics

6.5       Proteomics

6.6       Other Omics Technology

6.7       Imaging Technologies

6.8       Ultrasound

6.9       CT

6.10     MRI

6.11     PET

6.12     Mammography

6.13     Immunoassays

6.14     Cytogenetics

6.15     In Situ Hybridization

6.16     Other Cytogenetics

6.17     Bioinformatics

7.         By Application Overview

7.1       Introduction

7.1.1    Market Size & Forecast (Value)

7.2       Diagnostics

7.3       Research

7.4       Prognostics

7.5       Risk Assessment

7.6       Other Applications

8          Regional Overview

8.1       Introduction

8.1.1    Market Size & Forecast (Value)

8.2       America

8.2.1    North America

8.2.1.1 U.S.

8.2.1.1.1          By Type

8.2.1.1.2          By Cancer Type

8.2.1.2 Canada

8.2.1.2.1          By Type

8.2.1.2.2          By Cancer Type

8.2.1.3 Mexico

8.2.1.3.1          By Type

8.2.1.3.2          By Cancer Type

8.2.2    Latin America

8.2.2.1             By Type

8.2.2.4             By Application

8.3       Europe

8.3.1    Market Size & Forecast (Value)

8.3.2    Germany

8.3.2.1             By Type

8.3.2.2             By Cancer Type

8.3.3    France

8.3.3.1             By Type

8.3.3.2             By Cancer Type

8.3.4    U.K.

8.3.4.1             By Type

8.3.4.2             By Cancer Type

8.3.5    Italy

8.3.5.1             By Type

8.3.5.2             By Cancer Type

8.3.6    Spain

8.3.6.1             By Type

8.3.6.2             By Cancer Type

8.3.7    Rest of Europe

8.3.7.1             By Type

8.3.7.2             By Cancer Type

8.4       Asia Pacific

8.4.1    Market Size & Forecast (Value)

8.4.2    Japan

8.4.2.1             By Type

8.4.2.2             By Cancer Type

8.4.3    China

8.4.3.1             By Type

8.4.3.2             By Cancer Type

8.4.4    Australia

8.4.4.1             By Type

8.4.4.2             By Cancer Type

8.4.5    India

8.4.5.1             By Type

8.4.5.2             By Cancer Type

8.4.6    South Korea

8.4.6.1             By Type

8.4.6.2             By Cancer Type

8.4.7    Rest of Asia-Pacific

8.4.7.1             By Type

8.4.7.2             By Cancer Type

8.5       Middle East & Africa

8.5.1    Market Size & Forecast (Value)

8.5.2    Saudi Arabia

8.5.2.1             By Type

8.5.2.2             By Cancer Type

8.5.3    South Africa

8.5.3.1             By Type

8.5.3.2             By Cancer Type

8.5.4    Kuwait

8.5.4.1             By Type

8.5.4.2             By Cancer Type

8.5.5    Rest of Middle East & Africa

8.5.5.1             By Type

8.5.5.2             By Cancer Type

9          Company Profile

9.1       Thermo Fisher Scientific

9.1.1    Company Overview

9.1.2    Financial Performance

9.1.3    Recent Developments

9.1.4    Product Portfolio

9.2       Roche Diagnostics

9.2.1    Company Overview

9.2.2    Financial Performance

9.2.3    Recent Developments

9.2.4    Product Portfolio

9.3       Agilent Technologies

9.3.1    Company Overview

9.3.2    Financial Performance

9.3.3    Recent Developments

9.3.4    Product Portfolio

9.4       Illumina

9.4.1    Company Overview

9.4.2    Financial Performance

9.4.3    Recent Developments

9.4.4    Product Portfolio

9.5       Abbott

9.5.1    Company Overview

9.5.2    Financial Performance

9.5.3    Recent Developments

9.5.4    Product Portfolio

9.6       Qiagen N.V.

9.6.1    Company Overview

9.6.2    Financial Performance

9.6.3    Recent Developments

9.6.4    Product Portfolio

9.7       Merck & Co.

9.7.1    Company Overview

9.7.2    Financial Performance

9.7.3    Recent Developments

9.7.4    Product Portfolio

9.8       Becton Dickinson and Company

9.8.1    Company Overview

9.8.2    Financial Performance

9.8.3    Recent Developments

9.8.4    Product Portfolio

9.9       Becton Dickinson and Company

9.9.1    Company Overview

9.9.2    Financial Performance

9.9.3    Recent Developments

9.9.4    Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports